Apimeds Pharmaceuticals US (APUS) Total Current Liabilities (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Total Current Liabilities came in at $10.7 million in Q4 2025, up 945.21% YoY from $1.0 million in Q4 2024, and up 882.8% on a QoQ basis from $1.1 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Total Current Liabilities (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Total Current Liabilities data on file, last reported at $10.7 million in Q4 2025.
- Quarterly Total Current Liabilities rose 945.21% year-over-year to $10.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.7 million (up 945.21% YoY) and the FY2025 annual result came in at $10.7 million, up 945.21% from the prior year.
- Total Current Liabilities improved to $10.7 million in Q4 2025, from $1.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $10.7 million in Q4 2025 to a low of $123316.0 in Q4 2023.
- A 3-year average of $2.6 million and a median of $1.1 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities soared 730.66% — and 2025, when it surged 945.21%.
- Tracing APUS's Total Current Liabilities over 3 years: stood at $123316.0 in 2023, then soared by 730.66% to $1.0 million in 2024, then surged by 945.21% to $10.7 million in 2025.
- The last three Total Current Liabilities figures came in at $10.7 million (Q4 2025), $1.1 million (Q3 2025), and $809002.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Apimeds Pharmaceuticals US | 7.20 Mn | 7.20 Mn | - | 21.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 809,002.00 |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 123,316.00 |